| Literature DB >> 34682575 |
Shangmin Chen1,2, Weicong Cai1,3, Shiwei Duan4, Lijie Gao5, Wenda Yang1, Yang Gao6, Cunxian Jia5, Hongjuan Zhang7, Liping Li1,2.
Abstract
The catechol-O-methyltransferase (COMT) is a candidate gene to provide promising evidence of psychiatric disorders, but there is a knowledge gap between the genetic factor and multiple physical activity-related injuries (PARIs). The aim of this study was to explore the contribution of COMT to the risk of PARIs among university students in the Chinese Han population. We can further search for the intrinsic risk factors for the occurrence of multiple physical activity injuries and provide a scientific basis for early screening and precise intervention for the high-risk group of college students with multiple PARIs. A 1:1 matched case-control study of 61 PARIs cases and 61 healthy controls were carried out. DNA samples of the participants were isolated from saliva and genotyped on eight SNPs of the COMT gene (rs9265, rs4680, rs6269, rs4818, rs4633, rs165655, rs165656, and rs165722) using the MALDI-TOF MS method. We found that rs6269 and rs4818 were significantly associated with PARIs, and rs6269-GG and rs4818-GG contributed to the reduced risk of PARIs. Further haplotype analysis showed a four-marker C-G-C-G haplotype (rs165722-rs6269-rs4633-rs4818) acted with a protective role in the development of PARIs (p = 0.037; OR: 0.474, 95% CI: 0.269 to 0.834). However, the interactions between club membership and rs6269 or rs4818 would significantly increase the risk of PARIs (both p < 0.001, OR: 5.121 and 4.977, respectively). This is the first study to find the contribution of COMT to PARIs occurrence, suggesting that the COMT polymorphisms and the gene-environment interactions may alter the risk of PARIs.Entities:
Keywords: COMT; Catechol-O-methyltransferase; SNPs; physical activity; polymorphisms; sports injuries
Mesh:
Substances:
Year: 2021 PMID: 34682575 PMCID: PMC8535648 DOI: 10.3390/ijerph182010828
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Flow diagram of participants included in the study.
The differences between participants who agreed to participate in the interview and those who refused to participate.
| Characteristics | Responders ( | Non-Responders ( |
| |
|---|---|---|---|---|
| Gender | 0.938 | 0.333 | ||
| Male | 377 (26.5%) | 552 (28.0) | ||
| Female | 1 044 (73.5%) | 1417 (72.0) | ||
| Grade | 30.89 | 0.001 | ||
| Year 1 | 556 (39.1) | 620 (31.5) | ||
| Year 2 | 447 (31.5) | 605 (30.7) | ||
| Year 3 | 418 (29.4) | 744 (37.8) | ||
| Club member | 3.111 | 0.078 | ||
| Yes | 1065 (74.95) | 1527 (77.56) | ||
| No | 356 (25.05) | 442 (22.44) | ||
| Age (Years) | 20.09 ± 1.15 | 20.04 ± 1.38 | 0.575 | 0.561 |
| PA participation (min/wk) | 691.21 ± 632.64 | 537.90 ± 702.472 | 4.382 | 0.001 |
| PARI | 5.340 | 0.069 | ||
| 0 | 1 132 (79.7) | 1517 (77.1) | ||
| 1–2 | 227 (16.0) | 334 (17.0) | ||
| ≥3 | 62 (4.4) | 118 (5.9) |
Characteristics of physical activity-related injuries (PARIs) cases and non-PARI controls.
| Characteristics | Controls ( | Cases ( |
| |
|---|---|---|---|---|
| Gender | 0.000 | 1.000 | ||
| Male | 30 (49.2) | 30 (49.2) | ||
| Female | 31 (50.8) | 31 (50.8) | ||
| Grade | 0.000 | 1.000 | ||
| Year 1 | 28 (45.9) | 28 (45.9) | ||
| Year 2 | 20 (32.8) | 20 (32.8) | ||
| Year 3 | 13 (21.3) | 13 (21.3) | ||
| Club member | 30.500 | 0.001 | ||
| Yes | 10 (16.4) | 40 (65.6) | ||
| No | 51 (83.6) | 21 (34.4) | ||
| Age (Years) | 19.89 ± 1.02 | 20.02 ± 1.23 | −0.641 | 0.523 |
| BMI (kg/m2) | 20.24 ± 2.77 | 21.12 ± 3.30 | −1.593 | 0.114 |
| WHR | 0.78 ± 0.06 | 0.79 ± 0.06 | −0.086 | 0.932 |
| Screen time (hours/day) | 7.16 ± 2.78 | 6.66 ± 2.81 | 0.989 | 0.324 |
| PA participation (min/wk) | 781.38 ± 575.87 | 1070.41 ± 545.52 | −2.846 | 0.005 |
BMI, body mass index; WHR, waist-hip ratio; PA, physical activity. Figures in parentheses indicate percentages.
Allele and genotype distributions of the SNPs in the COMT gene in the PARIs cases and the non-PARI controls.
| SNPs | Controls | Cases | OR | |
|---|---|---|---|---|
| rs9265 | 0.482, 0.786 | |||
| CC | 17 (28.8) | 16 (27.6) | 1.000 (ref.) | |
| AC | 25 (42.4) | 28 (48.3) | 0.875 (0.327–2.339) | |
| AA | 17 (28.8) | 14 (24.1) | 1.190 (0.499–2.840) | |
| A% | 50.0 | 48.3 | 0.070, 0.792 | 0.933 (0.559–1.558) |
| rs4680 | 3.607, 0.165 | |||
| GG | 32 (56.1) | 23 (39.7) | 1.000 (ref.) | |
| AG | 24 (42.1) | 32 (55.2) | 1.855 (0.874–3.939) | |
| AA | 1 (1.8) | 3 (5.2) | 4.174 (0.408–42.716) | |
| A% | 22.8 | 32.8 | 2.835, 0.092 | 1.649 (0.919–2.959) |
| rs6269 | 6.047, 0.049 | |||
| AA | 20 (33.3) | 30 (50.8) | 1.000 (ref.) | |
| GA | 30 (50.0) | 26 (44.1) | 0.578 (0.267–1.250) | |
| GG | 10 (16.7) | 3 (5.1) | 0.200 (0.049–0.818) | |
| G% | 41.7 | 27.1 | 5.576, 0.018 | 0.521 (0.302–0.898) |
| rs4818 | 5.788, 0.055 | |||
| CC | 20 (32.8) | 30 (51.7) | 1.000 (ref.) | |
| GC | 32 (52.5) | 25 (43.1) | 0.521 (0.241–1.126) | |
| GG | 9 (14.8) | 3 (5.2) | 0.222 (0.054–0.923) | |
| G% | 41.0 | 26.7 | 5.385, 0.020 | 0.525 (0.304–0.908) |
| rs4633 | 1.995, 0.369 | |||
| CC | 39 (63.9) | 33 (54.1) | 1.000 (ref.) | |
| TC | 20 (32.8) | 23 (37.7) | 1.359 (0.637–2.899) | |
| TT | 2 (3.3) | 5 (8.2) | 2.955 (0.538–16.239) | |
| T% | 19.7 | 27.1 | 1.854, 0.173 | 1.514 (0.832–2.756) |
| rs165655 | 0.081, 0.960 | |||
| GG | 17 (27.9) | 18 (30.0) | 1.000 (ref.) | |
| AG | 34 (55.7) | 32 (53.3) | 0.889 (0.291–2.018) | |
| AA | 10 (16.4) | 10 (16.7) | 0.944(0.315–2.834) | |
| A% | 44.3 | 43.3 | 0.021, 0.884 | 0.963 (0.579–1.600) |
| rs165656 | 1.395, 0.498 | |||
| GG | 38 (63.3) | 32 (53.3) | 1.000 (ref.) | |
| CG | 19 (31.7) | 23 (38.3) | 1.438 (0.667–3.099) | |
| CC | 3 (5.0) | 5 (8.3) | 1.979 (0.439–8.929) | |
| C% | 20.8 | 27.5 | 1.455, 0.228 | 1.441 (0.795–2.615) |
| rs165722 | 1.019, 0.601 | |||
| CC | 37 (61.7) | 32 (55.2) | 1.000 (ref.) | |
| TC | 21 (35.0) | 22 (37.9) | 1.211 (0.565–2.957) | |
| TT | 2 (3.3) | 4 (6.9) | 2.312 (0.397–13.469) | |
| T% | 20.8 | 25.9 | 0.835, 0.361 | 1.326 (0.723–2.429) |
SNPs, single nucleotide polymorphisms; COMT, catechol-O-methyltransferase; A, Adenine; G, Guanine; C, Cytosine; T, Thymine. Figures in parentheses indicate percentages or 95% CIs.
Association of the dominant model and recessive model in the PARIs cases and the non-PARI controls.
| SNPs | OR (95% CI) 1 | OR (95% CI) 2 | OR (95% CI) 3 |
|---|---|---|---|
| rs9265 | |||
| DOM | 1.062 (0.457–2.378) | 0.693 (0.267–1.800) | 0.719 (0.273–1.897) |
| REC | 0.786 (0.345–1.792) | 0.875 (0.332–2.302) | 0.850 (0.297–2.437) |
| rs4680 | |||
| DOM | 1.948 (0.928–4.090) | 1.684 (0.726–3.908) | 1.938 (0.798–4.699) |
| REC | 3.055 (0.308–30.271) | 2.166 (0.168–27.946) | 0.967 (0.043–21.733) |
| rs6269 | |||
| DOM | 0.483 (0.230–1.014) | 0.370 (0.150–0.914) | 0.355 (0.137–0.918) |
| REC | 0.268 (0.070–1.028) | 0.426 (0.096–1.887) | 0.351 (0.075–1.641) |
| rs4818 | |||
| DOM | 0.455 (0.217–0.956) | 0.389 (0.161–0.938) | 0.364 (0.144–0.924) |
| REC | 0.315 (0.081–1.229) | 0.484 (0.107–2.182) | 0.385 (0.082–1.822) |
| rs4633 | |||
| DOM | 1.504 (0.728–3.108) | 1.427 (0.611–3.334) | 1.523 (0.626–3.707) |
| REC | 2.634 (0.491–14.134) | 3.255 (0.522–20.286) | 2.418 (0.324–18.037) |
| rs165655 | |||
| DOM | 0.902 (0.411–1.979) | 0.660 (0.262–1.663) | 0.711 (0.276–1.827) |
| REC | 1.020 (0.391–2.662) | 0.994 (0.314–3.144) | 0.900 (0.262–3.098) |
| rs165656 | |||
| DOM | 1.511 (0.728–3.316) | 1.418 (0.598–3.362) | 1.532 (0.616–3.813) |
| REC | 1.727 (0.394–7.577) | 2.118 (0.411–10.906) | 1.545 (0.237–10.079) |
| rs165722 | |||
| DOM | 1.307 (0.627–2.723) | 1.233 (0.525–2.899) | 1.320 (0.539–3.237) |
| REC | 2.148 (0.378–12.207) | 3.023 (0.465–19.631) | 2.214 (0.291–16.882) |
1: Adjusted for none covariate; 2: Adjusted for gender, grade, and sports team membership; 3: Adjusted for gender, grade, sports team membership, age, body mass index, waist-hip ratio, screen time, and PA participation; SNPs, single nucleotide polymorphisms; DOM, dominant model; REC, recessive model.
Figure 2Linkage disequilibrium correlation coefficients of the COMT SNPs.
Haplotype frequencies of the SNPs in the COMT gene in the PARIs cases and the non-PARI controls.
| Block | Haplotype | Controls | Cases |
| OR (95% CI) | |
|---|---|---|---|---|---|---|
| 1 a | ||||||
| C-A-C-C | 0.385 | 0.452 | 1.137 | 0.286 | 1.490 (0.876–2.533) | |
| C-G-C-G | 0.393 | 0.268 | 4.333 | 0.037 | 0.474 (0.269–0.834) | |
| T-A-T-C | 0.197 | 0.270 | 1.854 | 0.173 | 1.466 (0.786–2.735) | |
| 2 b | ||||||
| C-G | 0.499 | 0.522 | 0.131 | 0.717 | 1.111 (0.664–1.860) | |
| A-A | 0.443 | 0.441 | 0.001 | 0.980 | 0.992 (0.590–1.666) | |
| A-G | 0.059 | 0.037 | 0.621 | 0.431 | 0.577 (0.164–2.026) |
a: The bases of block one are listed in the following order: rs165722, rs6269, rs4633, and rs4818; b: The bases of block two are listed in the following order: rs9265 and rs165655; SNPs, single nucleotide polymorphisms; COMT, catechol-O-methyltransferase.